BRAZIL HAS ENOUGH INFECTION DATA TO ANALYZE SINOVACS COVID 19 VACCINE: SAYS OFFICIALS-

24 November

BRAZIL HAS ENOUGH INFECTION DATA TO ANALYZE SINOVACS COVID 19 VACCINE: SAYS OFFICIALS-

On monday brazil has gathered information from the china lab where they prepared vaccine for the deadly disease covid 19 and the reports were submitted to brazil will be doing the trails on monday and by december their strategy will be made correct.

Director of Butantan biomedical research institute Dimas Covas said that efficient results of the independent committee will be released on the first week of december.

Sinovac vaccine in Brazil is the last stage in make it available everywhere. He said that 74 confirmed cases among its trial patients and 61 initial milestone set for interim efficiency analysis.

On sunday ministry decided to buy vaccines from Pfizer Inc, India's Bharat Biotech, the Russian Direct Investment Fund, Moderna Inc and Janssen, a unit of Johnson & Johnson, but made no mention of Sinovac's candidate.
Chinese vaccine was attacked by
Bolsonaro and it was remained unclear whether the federal government will include it in its national inoculation program.

Sao Paulo's head João Gabbardo,he expects China's health regulator to approve Sinovac's CoronaVac in December, which could hasten approval in Brazil because it is the covid continent.